---
title: "ETNA-AD - Reviews, Revenue and Downloads in United States | Apple App Store"
description: "Eye Tracking Neurological Assessment (ETNA) is a family of science-based applications developed to aid with the evaluation and monitoring of neurological disorders. The ETNA-AD application is specific"
---

# ETNA-AD — United States
> Evaluation/monitoring of AD

![ETNA-AD App Icon](https://is1-ssl.mzstatic.com/image/thumb/Purple221/v4/c6/21/bc/c621bce9-563c-f525-9faa-10768c64b16a/ETNA_AD-0-0-1x_U007epad-0-1-85-220.png/434x0w.png)

**Developer:** [Unknown](https://apptail.io/developer/unknown-Keqd)
**Category:** Health Fitness
**Rating:** N/A (0 ratings)
**Price:** Free
**Bundle ID:** com.innodemneurosciences.ETNA-AD
**Store:** Apple App Store
**Country:** United States
**Version:** 1.0.18 (released 2026-11-01)
**Original Release:** 2023-11-08
**Languages:** English, French, Spanish

**App Store Link:** [Download on Apple App Store](https://apps.apple.com/us/app/app/id1622363703)
**AppTail Page:** [https://apptail.io/app/etna-ad-ddaB/united-states](https://apptail.io/app/etna-ad-ddaB/united-states)

## ETNA-AD Description
Eye Tracking Neurological Assessment (ETNA) is a family of science-based applications developed to aid with the evaluation and monitoring of neurological disorders. The ETNA-AD application is specifically designed for use in research-ethics-board (REB)-approved clinical studies where only approved study personnel and participants who have signed an REB-approved consent form will be able to use the application via a unique identifier code. The ETNA-AD application is designed to help investigate the link between eye movements recorded during visual tests presented on the iPad and standard measures of disease severity (stage) and cognitive status in patients with Alzheimer’s Disease (AD). To do so, the application makes use of Innodem Neurosciences' patented eye-tracking technology using the iPad's camera. The data collected by this application are being used to validate the application and its underlying algorithms within the context of REB-approved clinical studies. No data is currently being used to provide medical guidance to patients and/or medical professionals, and the application itself will not provide the user with any clinical or medical information following the completion of the visual tests.

## ETNA-AD Screenshots
- [Screenshot 1](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource112/v4/99/0c/19/990c19e5-301c-037b-2b34-a3382bb30a70/0c33fcee-a20e-492b-86c1-5e33de39cd15_iPad_Pro__U002812.9-inch_U0029__U00285th_generation_U0029-0.png/2048x2732.png)
- [Screenshot 2](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource122/v4/53/51/dd/5351dd82-bfff-dabe-b6e1-a93ab4d265b6/e0c263e2-c5a6-4a66-95b3-52ba458a9aa6_iPad_Pro__U002812.9-inch_U0029__U00285th_generation_U0029-1.png/2048x2732.png)
- [Screenshot 3](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource112/v4/58/9e/b9/589eb90a-4e55-9b70-1771-4c1586488869/1f153677-a3cc-47e6-8526-7644a0660fad_iPad_Pro__U002812.9-inch_U0029__U00285th_generation_U0029-2.png/2048x2732.png)
- [Screenshot 4](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource112/v4/53/1a/70/531a7032-855a-45af-47d6-6bfa06345fb5/792deb6e-3ab1-4d6e-ad77-51f19938a0aa_iPad_Pro__U002812.9-inch_U0029__U00285th_generation_U0029-3.png/2048x2732.png)
- [Screenshot 5](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource122/v4/7a/d9/6f/7ad96f27-a897-2f94-e88d-1aa189744b84/b5410c6c-6593-4325-849e-7972f56f167d_iPad_Pro__U002812.9-inch_U0029__U00285th_generation_U0029-4.png/2048x2732.png)
- [Screenshot 6](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource122/v4/1c/1f/49/1c1f49cf-aa4c-470a-6992-0265c0d5c76a/a1b672ea-8f7d-4457-840a-cbfe947519d3_iPad_Pro__U002812.9-inch_U0029__U00285th_generation_U0029-5.png/2048x2732.png)
- [Screenshot 7](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource112/v4/14/c2/b8/14c2b8a9-686c-53e1-2fcb-52ba48ebb0a3/4d75bc63-fa54-47e8-ad0c-0be25b469b3d_iPad_Pro__U002812.9-inch_U0029__U00285th_generation_U0029-6.png/2048x2732.png)
- [Screenshot 8](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource122/v4/2e/b2/d3/2eb2d313-98b3-1bfb-66c6-1f5b6ffd6626/6b8ae0fa-13c9-4d0e-9089-2568da874314_iPad_Pro__U002812.9-inch_U0029__U00285th_generation_U0029-7.png/2048x2732.png)
- [Screenshot 9](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource116/v4/63/4c/4b/634c4b25-2a23-7f85-0b24-a96a65b4b380/d1260f4e-8fb3-4308-8240-cb6b104f22c0_iPad_Pro__U002812.9-inch_U0029__U00285th_generation_U0029-8.png/2048x2732.png)
- [Screenshot 10](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource122/v4/d5/17/d4/d517d4fa-1976-6b47-d68a-c8caea357a06/42e7ab07-03e4-4f51-b02a-899272b36845_iPad_Pro__U002812.9-inch_U0029__U00285th_generation_U0029-9.png/2048x2732.png)






## Apps Similar to ETNA-AD
- [Chemo Brain Cognitive Research](https://apptail.io/app/chemo-brain-cognitive-research-Yaxc/united-states)
- [Alzheimer's](https://apptail.io/app/alzheimers-bVGc/united-states)
- [SimpleC Companion](https://apptail.io/app/simplec-companion-PJjd/united-states)
- [BGC Science](https://apptail.io/app/bgc-science-mXKi/united-states)
- [BoundaryCare Watch-Based GPS](https://apptail.io/app/boundarycare-watch-based-gps-sSPi/united-states)
- [New Look Eyewear](https://apptail.io/app/new-look-eyewear-OUzj/united-states)
- [TabCAT](https://apptail.io/app/tabcat-Qsbl/united-states)
- [outSMARTPD](https://apptail.io/app/outsmartpd-gOWp/united-states)
- [NMMP Mobile](https://apptail.io/app/nmmp-mobile-pcIq/united-states)


---

## About AppTail

[AppTail](https://apptail.io) is a mobile app intelligence platform providing app analytics, ASO (App Store Optimization) tools, keyword tracking, competitor analysis, revenue estimates, and review monitoring for iOS App Store apps. Track your app's performance, discover ranking keywords, monitor competitors, and analyze market trends.

- [Search Apps](https://apptail.io)
- [Top Charts](https://apptail.io/top-iphone-apps)
- [Sign Up for Full Access](https://app.apptail.io/signup?utm_campaign=ai-crawl&utm_content=footer)

*Data provided by [AppTail](https://apptail.io) - Mobile App Intelligence Platform*